Supplementary Figure from Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC

Kim Blenman,Michal Marczyk,Julia Foldi,Vignesh Gunasekharan,Andrea L. M. Silber,Lajos Pusztai

CANCER RESEARCH（2023）

引用 1|浏览19

暂无评分

摘要

Supplementary Figure from Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC

查看译文

关键词

Neoadjuvant Therapy,Biomarkers for Immunotherapy,Combination Therapies

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要